Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Bieck

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Psychiatrische Praxis|August 1, 1989
[Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies]P R Bieck
Advances in Cyclic Nucleotide Research|January 1, 1972
Role of cyclic AMP in the regulation of gastric secretion in dogs and humansP R Bieck
Psychopharmacology|January 1, 1987
Oral tyramine pressor test and the safety of MAO inhibitor drugsR Schulz, P R Bieck
Fortschritte Der Medizin|April 20, 1991
[Clinical drug trials. Part 2. Legal regulations, (EG-) guidelines, ethics commission]C H Gleiter, P R Bieck
Fortschritte Der Medizin|July 10, 1991
[Detection of side effects. 1: Spontaneous detection of drug risks--responsibility of the physician]C H Gleiter, P R Bieck
Journal of Neural Transmission. Supplementum|January 1, 1989
Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitorsP R Bieck, K H Antonin
Gut|December 1, 1987
Transdermal scopolamine and gastric acid secretionK H Antonin, P R Bieck
Fortschritte Der Medizin|February 20, 1991
[Clinical drug trials. 1: The 4 phases of clinical trials]C H Gleiter, P R Bieck
European Journal of Clinical Pharmacology|January 1, 1982
Monoamine oxidase inhibition by tranylcypromine: assessment in human volunteersP R Bieck, K H Antonin
Fortschritte Der Medizin|July 20, 1991
[Detection of side effects. 2: Responsibilities of the pharmaceutical industry, drug commissions, the Federal Health Office and international organizations]C H Gleiter, P R Bieck
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Psychiatrische Praxis|August 1, 1989
[Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies]P R Bieck
Advances in Cyclic Nucleotide Research|January 1, 1972
Role of cyclic AMP in the regulation of gastric secretion in dogs and humansP R Bieck
Psychopharmacology|January 1, 1987
Oral tyramine pressor test and the safety of MAO inhibitor drugsR Schulz, P R Bieck
Fortschritte Der Medizin|April 20, 1991
[Clinical drug trials. Part 2. Legal regulations, (EG-) guidelines, ethics commission]C H Gleiter, P R Bieck
Fortschritte Der Medizin|July 10, 1991
[Detection of side effects. 1: Spontaneous detection of drug risks--responsibility of the physician]C H Gleiter, P R Bieck
Journal of Neural Transmission. Supplementum|January 1, 1989
Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitorsP R Bieck, K H Antonin
Gut|December 1, 1987
Transdermal scopolamine and gastric acid secretionK H Antonin, P R Bieck
Fortschritte Der Medizin|February 20, 1991
[Clinical drug trials. 1: The 4 phases of clinical trials]C H Gleiter, P R Bieck
European Journal of Clinical Pharmacology|January 1, 1982
Monoamine oxidase inhibition by tranylcypromine: assessment in human volunteersP R Bieck, K H Antonin
Fortschritte Der Medizin|July 20, 1991
[Detection of side effects. 2: Responsibilities of the pharmaceutical industry, drug commissions, the Federal Health Office and international organizations]C H Gleiter, P R Bieck
Pageof 5